BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Botts SR, Fish JE, Howe KL. Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment. Front Pharmacol 2021;12:787541. [PMID: 35002720 DOI: 10.3389/fphar.2021.787541] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabbir MG, Wigle JT, Taylor CG, Zahradka P. Growth State-Dependent Expression of Arachidonate Lipoxygenases in the Human Endothelial Cell Line EA.hy926. Cells 2022;11:2478. [DOI: 10.3390/cells11162478] [Reference Citation Analysis]
2 Mioc M, Milan A, Malița D, Mioc A, Prodea A, Racoviceanu R, Ghiulai R, Cristea A, Căruntu F, Șoica C. Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I). IJMS 2022;23:7740. [DOI: 10.3390/ijms23147740] [Reference Citation Analysis]
3 Huang Z, Wu M, Zeng L, Wang D, Sun J. The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis. Cardiology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/4287711] [Reference Citation Analysis]
4 Li KX, Wang ZC, Machuki JO, Li MZ, Wu YJ, Niu MK, Yu KY, Lu QB, Sun HJ. Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension? Front Physiol 2022;13:848867. [PMID: 35530510 DOI: 10.3389/fphys.2022.848867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Adam CA, Șalaru DL, Prisacariu C, Marcu DTM, Sascău RA, Stătescu C. Novel Biomarkers of Atherosclerotic Vascular Disease-Latest Insights in the Research Field. Int J Mol Sci 2022;23:4998. [PMID: 35563387 DOI: 10.3390/ijms23094998] [Reference Citation Analysis]
6 Howe KL, Cybulsky M, Fish JE. The Endothelium as a Hub for Cellular Communication in Atherogenesis: Is There Directionality to the Message? Front Cardiovasc Med 2022;9:888390. [DOI: 10.3389/fcvm.2022.888390] [Reference Citation Analysis]
7 Dai Y, Chen D, Xu T. DNA Methylation Aberrant in Atherosclerosis. Front Pharmacol 2022;13:815977. [DOI: 10.3389/fphar.2022.815977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]